Medical treatment of cardiovascular disorders during pregnancy (original) (raw)

The effects of maternally administered digoxin upon the cardiovascular hemodynamics of the fetal lamb

Antonio Hernandez

American Heart Journal, 1973

View PDFchevron_right

Endogenous digoxin-immunoreactive substance in normal and preeclamptic pregnancies

tuncay özgünen

International Journal of Gynecology & Obstetrics, 1993

View PDFchevron_right

Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia

Ana Martín Suárez

Expert Review of Clinical Pharmacology, 2017

View PDFchevron_right

Maternal complications induced by digoxin treatment of fetal tachycardia: A retrospective series of 18 cases

Salma Touleimat

Journal of Gynecology Obstetrics and Human Reproduction, 2018

View PDFchevron_right

Significance of the endogenous digoxin-like substance in infants and mothers

Steven MacLeod

Clinical Pharmacology & Therapeutics, 1984

View PDFchevron_right

Perinatal Changes in a Digoxin-like Immunoreactive Substance

James King

Pediatric Research, 1984

View PDFchevron_right

RELEASE OF A SUBSTANCE FROM THE HUMAN PLACENTA HAVING DIGOXIN-LIKE IMMUNOREACTIVITY

Lorenzo Malatino

Clinical and Experimental Pharmacology and Physiology, 1993

View PDFchevron_right

Characterization of Digoxin-Like Materials in Human Cord Serum

Fred Chasalow

Annals of the New York Academy of Sciences, 1990

View PDFchevron_right

Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation☆☆☆

Philip Darney

American Journal of Obstetrics and Gynecology, 2000

View PDFchevron_right

Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro

Miriam Katz, Mahmoud Huleihel

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2003

View PDFchevron_right

Paradoxical behavior of serum digoxin concentrations in an anuric neonate

George Giacoia

The Journal of Pediatrics, 1977

View PDFchevron_right

Comparison between umbilical artery and vein endogenous digoxin-like immuno-active factor levels in normal and pre-eclamptic patients

Carl Lombard

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1991

View PDFchevron_right

Intra-fetal Compared With Intra-amniotic Digoxin Before Dilation and Evacuation

Katharine White

Obstetrics & Gynecology, 2016

View PDFchevron_right

Intra-amniotic Digoxin for Fetal Anomaly in Second and Early Third Trimester

B Shakya

Nepal Journal of Obstetrics and Gynaecology, 2014

View PDFchevron_right

Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae

Vladimir Kashkin

Journal of Hypertension, 2010

View PDFchevron_right

Atrial natriuretic factor, digoxin-like immunoreactive substance, norepinephrine, epinephrine, and plasma renin activity in human fetuses and their alteration by fetal disease

Carl Weiner

American journal of obstetrics and gynecology, 1988

View PDFchevron_right

Resolution of Fetal Hydrops Dependent on Sustained Fetal Supraventricular Tachycardia after Digoxin Therapy

egle savukyne

Medicina

View PDFchevron_right

Safety of digoxin for fetal demise before second-trimester abortion by dilation and evacuation

Gillian Dean

Contraception, 2012

View PDFchevron_right

Pregnancy and drugs for cardiovascular diseases

Mirela Erić

Acta Cardiologica, 2009

View PDFchevron_right

Rapid Assay for Determining D-Dimer Levels in Pregnancy

james anasti

Obstetrics & Gynecology, 2006

View PDFchevron_right

Clinical Therapeutics in Pregnancy

Donald Mattison

Journal of Biomedicine and Biotechnology, 2011

View PDFchevron_right

Endogenous substance in newborn infants causingfalse positive digoxin measurements

Roland Valdes

The Journal of Pediatrics, 1983

View PDFchevron_right

Digoxin and Amiodaron in Fetal Sustained Supraventricular Tachycardia and Nonimmune Hydrops

Marina Ivanisevic, Ivan Malčić

Gynaecologia Et Perinatologia, 2011

View PDFchevron_right

Medical Management of the Pregnant Patient

Maria Pia Quiroga Reategui

View PDFchevron_right

Cardiovascular Management in Pregnancy

Anne Valente

Circulation, 2015

View PDFchevron_right

Mammary Excretion of Digoxin in Goats

Muhammad Nawaz

Acta Pharmacologica Et Toxicologica, 2009

View PDFchevron_right

Elevation in D-dimer concentrations is positively correlated with gestation in normal uncomplicated pregnancy

Ekere Essien

International Journal of Women's Health, 2012

View PDFchevron_right

Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy

Steven Graves

American journal of hypertension, 1995

View PDFchevron_right

Gastrointestinal Symptoms as an Important Sign in Premature Newborns with Severely Increased S-Digoxin

Per Damkier

Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, 2005

View PDFchevron_right

A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors

Roland Valdes

PubMed, 1989

View PDFchevron_right